Journal of Assisted Reproduction and Genetics

, Volume 17, Issue 4, pp 194–199 | Cite as

Pentoxifylline Initiates Motility in Spontaneously Immotile Epididymal and Testicular Spermatozoa and Allows Normal Fertilization, Pregnancy, and Birth After Intracytoplasmic Sperm Injection

  • P. Terriou
  • E. Hans
  • C. Giorgetti
  • J. L. Spach
  • J. Salzmann
  • V. Urrutia
  • R. Roulier


Purpose: Pentoxifylline (PF) has been used to enhancesperm motility in many in vitro fertilization programs. Thetwofold purpose of this study was to determine whether PFstimulates fresh or frozen epididymal and testicular totallyimmotile spermatozoa and whether it can be used to selectviable spermatozoa for intracytoplasmic sperm injection(ICSI).

Methods: To test the effect of PF on motility, 10 samplesof totally immotile spermatozoa were incubated for 10 minwith 3.6 mM PF. Motility was initiated in all cases (14.8%mean motility after PF treatment of five samples of fresh orfrozen epididymal spermatozoa and 13.6% mean motility offive samples of fresh or frozen testicular spermatozoa). Toassess PF for selection of viable spermatozoa before ICSI,we compared the outcome of ICSI in 20 cycles using freshor frozen epididymal or testicular PF-treated immotilespermatozoa and 139 control ICSI using fresh or frozenepididymal or testicular spontaneously motile spermatozoa.

Results: Fertilization rates were similar in the PF andcontrol groups (45.2% vs. 51.0%). Embryo quality and divisionstages at the time of transfer were comparable. Sixpregnancies occurred in PF-ICSI group (30.0% per cycle vs. 26.6%in control group) including two deliveries of healthy childrenand four ongoing pregnancies.

Pentoxifylline immotile spermatozoa epididymal spermatozoa testicular spermatozoa 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aparicio NJ, Schwarzstein L, de Turner EA: Pentoxifillyne (BL 191) by oral administration in the treatment of asthénospermia. Andrologia 1980;12:228–231Google Scholar
  2. 2.
    Yovich JM, Edirisinghe WR, Cummins JM, Yovich JL: Preliminary results using pentoxyfillyne in a pronuclear stage tubal transfer (PROST) program for severe male factor infertility. Fertil Steril 1988;50:179–181Google Scholar
  3. 3.
    Negri P, Grechi E, Tomasi A, Fabbri E, Capuzzo A: Effectiveness of pentoxifylline in semen preparation for intauterine insemination. Hum Reprod 1996;6:1236–1239Google Scholar
  4. 4.
    Yovich JM, Edirisinghe WR, Cummins JM, Yovich JL: Influence of pentoxifillyne in severe male factor infertility. Fertil Steril 1990;53:715–722Google Scholar
  5. 5.
    Tesarik J, Thébault A, Testart J: Effect of pentoxifylline on sperm movement characteristics in normozoospermic and asthenozoospermic specimens. Hum Reprod 1992;7:1257–1263Google Scholar
  6. 6.
    Tesarik J, Mendoza C, Carreras A: Effects of phosphodiesterase inhibitors caffeine and pentoxifylline on spontaneous and stimulus-induced acrosome reactions in human sperm. Fertil Steril 1992;58:1185–1190Google Scholar
  7. 7.
    McKinney KA, Lewis SEM, Thompson W: Persistent effects of pentoxifylline on human sperm motility, after drug removal, in normozoospermic and asthenozoospermic individuals. Andrologia 1994;26:235–240Google Scholar
  8. 8.
    Liu J, Nagy Z, Joris H, Tournaye H, Smitz J, Camus M, Devroey P, Van Steirteghem A: Analysis of 76 total fertilization failure cycles out of 2732 intracytoplasmic sperm injection cycles. Hum Reprod 1995;10:2630–2636Google Scholar
  9. 9.
    Van Steirteghem AC, Liu J, Joris H, Nagy Z, Janssenswillen C, Tournaye H, Derde MP, Van Asshe E, Devroey P: Higher success rate by intracytoplasmic sperm injection than by subzonal insemination. Report of a second series of 300 consecutive treatment cycles. Hum Reprod 1993;7:1055–1060Google Scholar
  10. 10.
    Giorgetti C, Terriou P, Auquier P, Hans E, Spach JL, Salzmann J, Roulier R: Embryo score to predict implantation after in-vitro fertilization: Based on 957 single embryo transfers. Hum Reprod 1995;8:101–104Google Scholar
  11. 11.
    Yovich JL: Pentoxifylline: Actions and applications in assisted reproduction. Hum Reprod 1993;11:1786–1791Google Scholar
  12. 12.
    Dimitriadou F, Rizos D, Mantzavinos T, Arvaniti K, Voutsina K, Prapa A, Kanakas N: The effect of pentoxifylline on sperm motility, oocyte fertilization, embryo quality, and pregnancy outcome in an in vitro fertilization program. Fertil Steril 1995;4:880–886Google Scholar
  13. 13.
    Tournaye H, Devroey P, Camus M, Van der Linden M, Janssen R, Van Steirteghem A: Use of pentoxifylline in assisted reproductive technology. Hum Reprod 1995; 10 (suppl. 1):72–79Google Scholar
  14. 14.
    Tasdemir I, Tasdemir M, Tavukçuoglu S: Effect of pentoxifylline on immotile testicular spermatozoa. J Assist Reprod Genet 1998;15:90–92Google Scholar
  15. 15.
    Buch JP, Philips KA, Kolon TF: Cryopreservation of microsurgically extracted ductal sperm: Pentoxifylline enhancement of motility. Fertil Steril 1994;2:418–420Google Scholar
  16. 16.
    Nagy Z, Joris H, Verheyen G, Tournaye H, Devroey P, Van Steirteghem AC: Correlation between motility of testicular spermatozoa, testicular histology and the outcome of intracytoplasmic sperm injection. Hum Reprod 1998;4:890–895Google Scholar
  17. 17.
    Nodar F, De Vincentiis S, Olmedo SB, Papier S, Urrutia F, Acostaa AA: Birth of twin males with normal karyotype after intracytoplasmic sperm injection with use of testicular spermatozoa from a nonmosaic patient with Klinefelter's syndrome. Fertil Steril 1999;71:1149–1152Google Scholar
  18. 18.
    Tournaye H, Van der Linden M, Van den Abbeel E, Devroey P, Van Steirteghem A: Effects of pentoxifylline on in-vitro development of preimplantation mouse embryos. Hum Reprod 1993;8:1475–1480Google Scholar
  19. 19.
    Tournaye H, Van der Linden M, Van den Abbeel E, Devroey P, Van Steirteghem A: Effects of pentoxifylline on implantation and post-implantation development of mouse embryos in vitro. Hum Reprod 1993;8:1948–1954Google Scholar
  20. 20.
    Tournaye H, Van der Linden M, Van den Abbeel E, Devroey P, Van Steirteghem A: The effect of pentoxifylline on mouse in-vitro fertilization and early embryonic development. Hum Reprod 1994;9:1903–1908Google Scholar
  21. 21.
    Lacham-Kaplan O, Trouson A: The effects of the sperm motility activators 2-deoxyadenosine and pentoxifylline used for sperm microinjection on mouse and human embryo development. Hum Reprod 1993;6:945–952Google Scholar
  22. 22.
    Casper RF, Meriano JS, Jarvi KA, Cowan L, Lucato ML: The hypo-osmotic swelling test for selection of viable sperm for intracytoplasmic sperm injection in men with complete asthenozoospermia. Fertil Steril 1996;5:972–976Google Scholar
  23. 23.
    Vandervorst M, Tournaye H, Camus M, Nagy ZP, Van Steirteghem A, Devroey P: Patients with absolutly immotile spermatozoa and intracytoplasmic sperm injection. Hum Reprod 1997;11:2429–2433Google Scholar
  24. 24.
    Verheyen G, Joris H, Crits K, Nagy Z, Tournaye H, Van Steirteghem A: Comparison of different hypo-osmotic swelling solutions to select viable immotile spermatozoa for potential use in intracytoplasmic sperm injection. Hum Reprod 1997;3:195–203Google Scholar
  25. 25.
    Vendrell FJ, Rubio C, Tarin JJ: The heparin-glutathione test: An alternative to the hypo-osmotic swelling test to select viable sperm for intracytoplasmic sperm injection. Fertil Steril 1998;70(6):1156–1161Google Scholar

Copyright information

© Plenum Publishing Corporation 2000

Authors and Affiliations

  • P. Terriou
    • 1
  • E. Hans
  • C. Giorgetti
    • 1
  • J. L. Spach
    • 1
  • J. Salzmann
    • 1
  • V. Urrutia
    • 1
  • R. Roulier
    • 1
  1. 1.Institut de Médecine de la ReproductionMarseilleFrance

Personalised recommendations